eCite Digital Repository

Inflammatory bowel disease

Citation

Jeffrey, EC and Bereznicki, LRE, Inflammatory bowel disease, Australian Pharmacist, 28, (6) pp. 504-509. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]


Preview
PDF
620Kb
  

Official URL: http://www.psa.org.au/?id=4497

Abstract

Inflammatory bowel disease (IBD) refers to a group of disorders characterised by chronic, relapsing inflammation in the gut.The main forms of IBD are Cronn's disease (CD) and ulcerative colitis (UC). The clinical course of both diseases can range from a mild form, in which the patient reaches long term remission without taking permanent medication, to a chronic active form, in which remission is only reached by permanently taking immunosuppressives and/orbioloqicals.' Approximately 61,000 Australians have lBO, with 1600new cases diagnosed each year. 2lBD can bediagnosed at any age, but has a peak onset between 15to 40years.

Item Details

Item Type:Professional, Non Refereed Article
Keywords:inflammatory bowel disease
Research Division:Medical and Health Sciences
Research Group:Pharmacology and Pharmaceutical Sciences
Research Field:Clinical Pharmacy and Pharmacy Practice
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Digestive System Disorders
Author:Jeffrey, EC (Mrs Ella van Tienen)
Author:Bereznicki, LRE (Professor Luke Bereznicki)
ID Code:57731
Year Published:2009
Deposited By:Pharmacy
Deposited On:2009-08-11
Last Modified:2010-10-06
Downloads:411 View Download Statistics

Repository Staff Only: item control page